ArticleInternational journal of cancer2012

Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts.

Gunamani Sithanandam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.